Beyond Next Ventures

Sakana Dream is a Japanese company specializing in aquaculture innovation. It employs a unique breeding technology called Surrogate Broodstock Technology to select and breed exceptional fish from over 4,000 species found in Japan. The company's focus is on creating hybrid fish that combine excellent taste with high productivity, aiming to contribute to sustainable and eco-friendly fish farming practices.

Umami United is a Japanese-inspired plant-based food brand focused on enriching the alternative protein market with unique and innovative ingredients. The company specializes in creating products that deliver intense umami flavor, appealing to both vegan consumers and those seeking healthier food options. Its flagship product, UMAMI Egg, is formulated primarily from konjac powder, showcasing the brand's commitment to leveraging Japanese culinary traditions and technology to develop its offerings. By providing plant-based alternatives to traditional eggs and meat, Umami United aims to broaden choices for the growing vegan population while promoting a flavorful and nutritious diet.

Olive Union Inc. is a company that focuses on developing innovative hearing aids aimed at improving the experience of individuals with hearing impairments. Founded in 2016 and headquartered in Tokyo, Japan, Olive Union utilizes advanced sound algorithms to create next-generation hearing solutions that integrate seamlessly with everyday technology. Their flagship device features a hearing process engine capable of making and receiving calls, as well as streaming music. Additionally, the device connects to a smartphone application for conducting hearing tests, which automatically adjusts audio frequencies to optimize sound quality while minimizing background noise. By addressing the common challenges of high costs and social stigma associated with traditional hearing aids, Olive Union aims to provide users with an accessible and effective solution for enhanced auditory experiences.

Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.

Integriculture develops cellular agriculture products including clean meat and clean foie gras, and offers scientific visual content production. Founded in 2015 and based in Tokyo, Japan, the company aims to enhance sustainability and food security by enabling scalable cell culture. Its patented general-purpose large-scale cell culture system can culture a wide range of cells without external growth factors, enabling affordable clean processed meat. This technology supports the production of safer, more sustainable alternatives to conventional meat and broader access to cellular agriculture solutions.

KOALA Tech is a high-tech company based in Fukuoka, Japan, focused on developing organic semiconductor laser diodes. Founded in 2019, it aims to enable practical applications of the world's first organic semiconductor laser diode realized at the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University. The company's laser diode technology is based on organic fluorescent semiconductors, which are generally easier to process into thin films, offering a potentially low-cost light source that can be integrated with organic light-emitting diode and other organic electronic platforms.

Acompany Co., Ltd., established in 2018 and headquartered in Aichi, Japan, specializes in designing and developing confidential computing systems. The company offers comprehensive support, from concept design to product development, for projects utilizing secret calculation and blockchain technology. It also provides data security consulting services and offers a blockchain application development course. Acompany's core focus is to provide privacy protection solutions, enabling secure data utilization and contributing to a safer data society.

LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

Olive Union Inc. is a company that focuses on developing innovative hearing aids aimed at improving the experience of individuals with hearing impairments. Founded in 2016 and headquartered in Tokyo, Japan, Olive Union utilizes advanced sound algorithms to create next-generation hearing solutions that integrate seamlessly with everyday technology. Their flagship device features a hearing process engine capable of making and receiving calls, as well as streaming music. Additionally, the device connects to a smartphone application for conducting hearing tests, which automatically adjusts audio frequencies to optimize sound quality while minimizing background noise. By addressing the common challenges of high costs and social stigma associated with traditional hearing aids, Olive Union aims to provide users with an accessible and effective solution for enhanced auditory experiences.

Anaut develops artificial intelligence–based software for surgical support. Its platform analyzes complex internal information in real time during procedures, assisting surgeons with image analysis and recognition of body structures. By continuously training on a large set of surgical videos, the system improves accuracy, expands detectable anatomy, and enables cross‑sectional analysis of thoracic, abdominal, and pelvic surgeries. The technology enhances intraoperative visualization, supports decision‑making, and helps manage potential complications.

Founded in 2019, MabGenesis is a biopharmaceutical company based in Yokohama, Japan. It specializes in developing therapeutic monoclonal antibody drugs for both human and animal use.

Integriculture develops cellular agriculture products including clean meat and clean foie gras, and offers scientific visual content production. Founded in 2015 and based in Tokyo, Japan, the company aims to enhance sustainability and food security by enabling scalable cell culture. Its patented general-purpose large-scale cell culture system can culture a wide range of cells without external growth factors, enabling affordable clean processed meat. This technology supports the production of safer, more sustainable alternatives to conventional meat and broader access to cellular agriculture solutions.

Founded in 2019, MabGenesis is a biopharmaceutical company based in Yokohama, Japan. It specializes in developing therapeutic monoclonal antibody drugs for both human and animal use.

Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.

KOALA Tech is a high-tech company based in Fukuoka, Japan, focused on developing organic semiconductor laser diodes. Founded in 2019, it aims to enable practical applications of the world's first organic semiconductor laser diode realized at the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University. The company's laser diode technology is based on organic fluorescent semiconductors, which are generally easier to process into thin films, offering a potentially low-cost light source that can be integrated with organic light-emitting diode and other organic electronic platforms.

Sonoligo Inc. is an internet-based company founded in 2018 and headquartered in Kariya, Japan. It operates an online platform that offers access to a variety of cultural events, including music, sports, and art, through a monthly subscription model. The platform enables users to participate in real events, engage with online experiences, and view video content tailored to diverse interests and age groups. By providing a flat rate service, Sonoligo aims to make cultural experiences accessible to a wide audience.

Vitaars, known as T-ICU Co., Ltd., is a Japanese company headquartered in Kobe that specializes in remote medical support for intensive care unit (ICU) operations. The company addresses the critical shortage of intensivists in Japan by offering a remote consultation system called "RELIEVE," which provides 24/7 support from a team of experienced intensivists and certified intensive care nurses. This system enables non-specialized doctors to manage critically ill patients more effectively, alleviating the stress associated with high-stakes medical situations. In addition to tele-intensive care consultations, Vitaars also offers training for healthcare professionals in intensive and emergency care, enhancing their skills and improving patient outcomes. Through its innovative services, Vitaars ensures that patients receive essential intensive care regardless of their location or the time of day.

KOALA Tech is a high-tech company based in Fukuoka, Japan, focused on developing organic semiconductor laser diodes. Founded in 2019, it aims to enable practical applications of the world's first organic semiconductor laser diode realized at the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University. The company's laser diode technology is based on organic fluorescent semiconductors, which are generally easier to process into thin films, offering a potentially low-cost light source that can be integrated with organic light-emitting diode and other organic electronic platforms.

miup, Inc. is a healthcare company founded in 2015 and based in Tokyo, Japan. It focuses on providing medical care services both in Asia and internationally, with an emphasis on preventive care and data collection in emerging markets. The company operates clinical testing centers and offers delivery-type medical examinations and telemedicine services. Additionally, miup develops laboratory information systems and customer management systems that utilize AI for screening and interview assistance, which enables medical professionals to deliver personalized care more efficiently. By leveraging vital data to improve diagnostic assistance and risk prediction accuracy, miup aims to create a comprehensive wellness ecosystem that enhances health management, diagnosis, and prevention for individuals globally.

Founded in 2006, QD Laser specializes in manufacturing quantum dot semiconductor lasers and wafers for various applications such as communications, industrial processing, and medical imaging. Its product portfolio includes picosecond lasers for precision machining, color-specific lasers for biological sciences, laser arrays for silicon optical circuits, and broadband gain chips for ophthalmic testing. Headquartered in Kawasaki, Japan, the company serves diverse industries including telecommunications, manufacturing, medicine, and consumer products.

Vitaars, known as T-ICU Co., Ltd., is a Japanese company headquartered in Kobe that specializes in remote medical support for intensive care unit (ICU) operations. The company addresses the critical shortage of intensivists in Japan by offering a remote consultation system called "RELIEVE," which provides 24/7 support from a team of experienced intensivists and certified intensive care nurses. This system enables non-specialized doctors to manage critically ill patients more effectively, alleviating the stress associated with high-stakes medical situations. In addition to tele-intensive care consultations, Vitaars also offers training for healthcare professionals in intensive and emergency care, enhancing their skills and improving patient outcomes. Through its innovative services, Vitaars ensures that patients receive essential intensive care regardless of their location or the time of day.

Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.

Integriculture develops cellular agriculture products including clean meat and clean foie gras, and offers scientific visual content production. Founded in 2015 and based in Tokyo, Japan, the company aims to enhance sustainability and food security by enabling scalable cell culture. Its patented general-purpose large-scale cell culture system can culture a wide range of cells without external growth factors, enabling affordable clean processed meat. This technology supports the production of safer, more sustainable alternatives to conventional meat and broader access to cellular agriculture solutions.

Lily MedTech Inc. is a medical device company based in Tokyo, Japan, founded in 2016. It specializes in the development and manufacture of innovative ultrasound diagnostic imaging equipment specifically designed for breast cancer detection. The company's flagship product is a ring echo device that utilizes a ring-type ultrasonic transducer to capture 3D images of the entire breast. This technology allows for a non-deforming examination process, which minimizes discomfort and reduces exposure to risks during diagnostic procedures. Lily MedTech's focus on enhancing breast ultrasound diagnostics aims to improve the overall experience for both patients and healthcare providers.

Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.

Repertoire Genesis, Inc. is a healthcare technology company based in Ibaraki, Japan, founded in 2014. The company specializes in the development of analytical software for T cell and B cell receptor repertoires, which plays a crucial role in advancing personalized medicine. By utilizing immune diversity analysis and neo-epithelial analysis, Repertoire Genesis aims to support the creation of innovative diagnostic and therapeutic methods. Through strategic partnerships with academic institutions and pharmaceutical companies, the company enhances its capability to deliver effective healthcare solutions to patients globally.

Myoridge Co. Ltd., established in 2016 and headquartered in Kyoto, Japan, specializes in developing a suspension culture system for scalable differentiation of pluripotent cells into desired cell types, notably cardiomyocytes. The company's innovative process employs a proprietary small-molecule compound, eliminating the need for proteins, thereby reducing production costs and ensuring lot-to-lot uniformity. Myoridge offers iPS cell-derived cardiomyocytes, cardiomyocyte fibers, and software for myocardial motion/fluorescence analysis, enabling advancements in regenerative medicine and drug discovery research.

CureApp, Inc. is a Tokyo-based digital health startup founded in 2014, specializing in the development of mobile applications aimed at treating various diseases. The company is recognized for its innovative approach to healthcare, particularly with its nicotine addiction treatment app launched in February 2015, which was developed in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp’s platform not only promotes clinical trials but also focuses on providing real-time, personalized guidance for lifestyle diseases through a cloud-based system that analyzes daily activity logs. This enables patients to manage their conditions more effectively, addressing health issues that are often overlooked by traditional medications and devices.

Repertoire Genesis, Inc. is a healthcare technology company based in Ibaraki, Japan, founded in 2014. The company specializes in the development of analytical software for T cell and B cell receptor repertoires, which plays a crucial role in advancing personalized medicine. By utilizing immune diversity analysis and neo-epithelial analysis, Repertoire Genesis aims to support the creation of innovative diagnostic and therapeutic methods. Through strategic partnerships with academic institutions and pharmaceutical companies, the company enhances its capability to deliver effective healthcare solutions to patients globally.

Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.

CureApp, Inc. is a Tokyo-based digital health startup founded in 2014, specializing in the development of mobile applications aimed at treating various diseases. The company is recognized for its innovative approach to healthcare, particularly with its nicotine addiction treatment app launched in February 2015, which was developed in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp’s platform not only promotes clinical trials but also focuses on providing real-time, personalized guidance for lifestyle diseases through a cloud-based system that analyzes daily activity logs. This enables patients to manage their conditions more effectively, addressing health issues that are often overlooked by traditional medications and devices.

Acompany Co., Ltd., established in 2018 and headquartered in Aichi, Japan, specializes in designing and developing confidential computing systems. The company offers comprehensive support, from concept design to product development, for projects utilizing secret calculation and blockchain technology. It also provides data security consulting services and offers a blockchain application development course. Acompany's core focus is to provide privacy protection solutions, enabling secure data utilization and contributing to a safer data society.